Advertisement

Inflammation Research

, Volume 45, Issue 10, pp 491–493 | Cite as

Effect if bucillamine on the rat trinitrobenzene sulfonic acid induced model of colitis

  • A. Kiano
  • N. Oshitani
  • H. Okabe
  • J. Hara
  • N. Suzuki
  • T. Aoki
  • K. Adachi
  • Y. Wanatabe
  • K. Yasuda
  • A. Tabata
  • M. Obayashi
  • S. Nakamura
  • A. Obata
  • T. Matsumoto
  • K. Okawa
  • K. Kobayashi
Original Research Papers

Keywords

Sulfonic Acid Trinitrobenzene Bucillamine Trinitrobenzene Sulfonic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Kitano A, Kobayashi K, Murai M, Tanaka Y, Katayama T, Yamamoto S. Study of experimental ulcerative colitis in the rabbit. Jpn J Gastroenterol 1978;75:1719–26.Google Scholar
  2. [2]
    Kitano A, Kobayashi K, Oshiumi H, Okawa K, Oka S, Ono T. Studies of experimental ulcerative colitis induced by carrageenan in the rabbit. Jpn J Gastroenterol 1981;78: 2104–11.Google Scholar
  3. [3]
    Kitano A, Matsumoto T, Hiki M, Hashimura H, Yoshiyasu K, Kobayashi K. Epithelial dysplasia of the rabbit colon induced by degraded carrageenan. Cancer Res 1986;46:1374–6.PubMedGoogle Scholar
  4. [4]
    Matsumoto T, Kitano A, Oshitani N, Obata A, Hiki M, Hashimura H, et al. Immunoglobulin-containing cells in the colonic mucosa of rabbits with carrageenan-induced colitis. Dis Colon Rectum 1988;31:723–9.CrossRefGoogle Scholar
  5. [5]
    Kitano A, Matsumoto T, Tabata A, Obayashi M, Nakagawa M, Watanabe Y, et al. Anti-inflammatory effects of the betamethasone sodium phosphate enema on carrageenan induced colitis in the rabbit. Jpn J Gastroenterol 1993;90:24–31.Google Scholar
  6. [6]
    Kitano A, Matsumoto T, Nakamura S, Oshitani N, Obata A, Nagura H, et al. Multifunctional effects of anticomplementary agent K-76 on carrageenan-induced colitis in the rabbit. Clin Exp Immunol 1993;94:348–53.CrossRefGoogle Scholar
  7. [7]
    Kitano A, Matsumoto T, Tabata A, Obayashi M, Nakagawa M, Yasuda K, et al. Anti-inflammatory effect of bucillamine on carrageenan-induced colitis in the rabbit. Int J Immunother 1994;10:135–43.Google Scholar
  8. [8]
    Morris GP, Rebeiro L, Herride MM, Szewczuk M, Edpew W. An animal model of chronic granulomatous inflammation of the stomach and colon [abstract]. Gastroenterology 1984;88:1332.Google Scholar
  9. [9]
    Kashiwazaki S, Shiokawa Y. Bucillamine: a new immunomodulator. Int J Immunother 1987;3:1–6.Google Scholar
  10. [10]
    Abe C. Clinical evaluation of immunomodulators. Int J Immunother 1985;1:7–10.Google Scholar
  11. [11]
    Matsuno H, Kitano T, Matsushita I, Tsuji H, Ochiai H. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis. Drugs Exp Clin Res 1993;19:205–11.PubMedGoogle Scholar
  12. [12]
    Wallace JL, Wallace K, MacNaughton, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29–36.CrossRefGoogle Scholar
  13. [13]
    Hayashi M, Matsunaga K, Okahara A, Mita S. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats. J Rheumatol 1991;18:691–5.PubMedGoogle Scholar
  14. [14]
    Isozaki T, Kimura M, Ikegaya N, Arai T, Fujigaki Y, Hishida A, et al. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and reviews of the literature. Clin Invest 1992;70:1036–42.CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag 1996

Authors and Affiliations

  • A. Kiano
  • N. Oshitani
  • H. Okabe
  • J. Hara
  • N. Suzuki
  • T. Aoki
  • K. Adachi
  • Y. Wanatabe
  • K. Yasuda
  • A. Tabata
  • M. Obayashi
  • S. Nakamura
  • A. Obata
  • T. Matsumoto
  • K. Okawa
  • K. Kobayashi

There are no affiliations available

Personalised recommendations